Modulation of transforming growth factor-β secretion from malignant glioma cells by interleukin-1β

Neurologia Medico-Chirurgica

Volumn 36, Issue 3, 1996, Pages 145-150

  Naganuma, Hirofumi ^a   Sasaki, Atsushi ^a   Satoh, Eiji ^a   Nagasaka, Mitsuyasu ^a   Nakano, Shin ^a   Isoe, Shiro ^a   Nukui, Hideaki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

interleukin 1 ; malignant glioma; transforming growth factor

Indexed keywords

INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA; HUMAN; HUMAN CELL; TUMOR GROWTH; TUMOR IMMUNOLOGY;

EID: 0029964163     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.36.145     Document Type: Article

References (46)

1. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA: An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A 86: 4544-4548, 1989
2. Bodmer S, Strommer K, Frei K, Spiel C, de Tribolet N, Heid I, Fontana A: Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β2. J Immunol 143: 3222-3229, 1989
3. Brown PD, Wakefield LM, Levinson AD, Sporn MB: Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, 3. Growth Factors 3: 35-43, 1990
4. Cinque S, Willems J, Depraetere S, Vermeire L, Joniau M: "In vitro" effect of interleukin-1β on human glioma cell lines: Regulation of cell proliferation and IL-6 production. Immunol Lett 34: 267-271, 1992
5. Danforth DN Jr, Sgagias MK: Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 53: 1538-1545, 1993
6. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM, Bodmer S, Fontana A, Hofer E: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6: 3673-3677, 1987
7. Dubinett SM, Huang M, Dhanani S, McBride WH: Interleukin-7 down regulates fibrosarcoma production of transforming growth factor-β. Proceeding of American Association of Cancer Research 34:462, 1993
8. Dubinett SM, Huang M, Dhanani S, Wang J, Beroiza T: Down-regulation of macrophage transforming growth factor-β messenger RNA expression by IL-7. J Immunol 151: 6670-6680, 1993
9. Espevik T, Figari IS, Ranges GE, Palladino MA Jr: Transforming growth factor-β1 (TGF-β1) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-β1 and TGF-β2, and recombinant human TGF-β1. J Immunol 140: 2312-2316, 1988
10. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166: 571-576, 1987
11. Fontana A, Frei K, Bodmer E, Hofer E, Schreier MH, Palladino MA Jr, Zinkernagel RM: Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J Immunol 143: 3230-3234, 1989
12. Fontana A, Hengartner H, de Tribolet N, Weber E: Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2 mediated effects. J Immunol 132: 1837-1844, 1984
13. Franks AJ, Ellis E: Immunohistochemical localization of tissue plasminogen activator in human brain tumors. Br J Cancer 59: 462-466, 1989
14. Frei K, Piani D, Malipiero UV, Van Meir E, de Tribolet N, Fontana A: Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148: 3140-3146, 1992
15. Gamble JR, Vadas MA: Endothelial cell adhesiveness for human T lymphocytes inhibited by transforming growth factor beta. J Immunol 146: 1149-1154, 1991
16. Gauthier T, Hamou MF, Monod L, Gaily P, Carrel S, de Tribolet N: Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo. Acta Neurochir (Wien) 121: 199-205, 1993
17. Hirte H, Clark DA: Generation of lymphokine activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-beta as a suppressor factor. Cancer Immunol Immunother 32: 296-302, 1991
18. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS: Transforming growth factor-β is an important immunoregulatory protein for human B lymphocytes. J Immunol 137: 3855-3860, 1986
19. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037-1050, 1986
20. Kuppner MC, Hamou M-F, Sawamura Y, Bodmer S, de Tribolet N: Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2. J Neurosurg 71: 211-217, 1989
21. Lee JC, Simon PL, Young PR: Constitutive and PMA-induced interleukin-1 production by the human astrocytoma cell line T24. Cell Immunol 118: 298-311, 1989
22. Lichtor T, Dohrmann GJ, Gurney ME: Cytokine gene expression by human gliomas. Neurosurgery 26: 788-793, 1990
23. Maruno M, Kovach JS, Kelly PJ, Yanagihara T: Transforming growth factor-α, epidermal growth fac-tor receptor, and proliferating potential in benign and malignant gliomas. J Neurosurg 75: 97-102, 1991
24. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN: Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance. J Neurosurg 76: 799-804, 1992
25. Morita M, Kasahara T, Mukaida N, Matsushima K, Nagashima T, Nishizawa M, Yoshida M: Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues. Eur Cytokine Netw 4: 351-358, 1993
26. Naganuma H, Sasaki A, Nukui H, Tasaka K: Antiproliferative cytokines secreted by lymphokine-activated killer cells stimulated with tumor cells. J Neurosurg 77: 411-416, 1992
27. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S, Tasaka K, Nukui H: Inhibition of tumor necrosis factor-α and -β secretion by lymphokine activated killer cells by transforming growth factor-β. Jpn J Cancer Res 85: 952-957, 1994
28. Naganuma H, Sasaki A, Satoh E, Sakihama T, Tasaka K, Nukui H: Improved bioassay for the detection of transforming growth factor-β1 and β2 in malignant gliomas. Neurol Med Chir (Tokyo) 34: 143-149, 1994
29. Nister M, Heldin CH, Westermark B: Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. Cancer Res 46: 332-340, 1986
30. Nitta T, Sato K: Expression of interleukin-6 gene in human astrocyte cell lineages. Journal of Clinical Neuroscience 1: 53-57, 1994
31. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW: Regulation of rat pulmonary artery endothelial cell transforming growth factor-β production by IL-1β and tumor necrosis factor-α. J Immunol 149: 103-106, 1992
32. Ranges GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J Exp Med 166: 991-998, 1987
33. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136: 3916-3920, 1986
34. Sandberg AC, Engberg C, Lake M, von Holst H, Sara VR: The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 93: 114-119, 1988
35. Sasaki A, Naganuma H, Satoh E, Nagasaka M, Isoe S, Nakano S Nukui H: Secretion of transforming growth factor-β1 and -β2 by malignant glioma cells. Neurol Med Chir (Tokyo) 35: 423-430, 1995
36. Schneider J, Hofman FM, Apuzzo MLJ, Hinton DR: Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77: 265-273, 1992
37. Sporn MB, Roberts AB, Wakefield LM, Assoian RK: Transforming growth factor-β: Biological function and chemical structure. Science 233: 532-534, 1986
38. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 105: 1039-1045, 1987
39. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda M, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710-5714, 1990
40. Takiuchi H, Tada T, Li XF, Ogata M, Ikeda T, Fujimoto S, Fujiwara H, Hamaoka T: Particular types of tumor cells have the capacity to convert transforming growth factor-β from a latent to an active form. Cancer Res 52: 5641-5646, 1992
41. Tanaka S, Nagashima T, Manaka S, Hori T, Yasumoto S: Growth suppression and astrocytic differentiation of glioma cells by interleukin-1. J Neurosurg 81: 402-410, 1994
42. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA: A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A 87: 1486-1490, 1990
43. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, de Tribolet N: Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52: 4297-4305, 1992
44. Van Meir E, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N: Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50: 6683-6688, 1990
45. Wrann M, Bodmer S, de Martin R, Spiel C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A: T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β. EMBO J 6: 1633-1636, 1987
46. Yamanaka R, Tanaka R, Yoshida S: Effects of irradiation on cytokine production in glioma cell lines. Neurol Med Chir (Tokyo) 33: 744-748, 1993